| 英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
| 2-Methyl-4-penten-1-ol 5673-98-3 |
|
5673-98-3 |
詳細(xì)
|
| 4,5-Dichloro-3,6-dihydroxyphthalonitrile 4640-41-9 |
DDQ副產(chǎn)物 |
4640-41-9 |
詳細(xì)
|
| 2-[3,5-Bis(trifluoromethyl)phenyl]propanoicacid 289686-73-3 |
2-[3,5-Bis(trifluoromethyl)phenyl]propanoic Acid |
289686-73-3 |
詳細(xì)
|
| TriamtereneEPImpurityC 19152-93-3 |
氨苯蝶啶雜質(zhì)C |
19152-93-3 |
詳細(xì)
|
| LovastatinEPImpurityB75225-50-2 |
洛伐他汀鈉 |
75225-50-2 |
詳細(xì)
|
| NebivololDidesfluoro129101-33-3 |
二脫氟奈必洛爾 |
129101-33-3 |
詳細(xì)
|
| 2,4,6,3',5'-pentamethoxybiphenyl 84212-55-5 |
2,4,6,3',5'-PENTAMETHOXYBIPHENYL |
84212-55-5 |
詳細(xì)
|
| Methyl2-acetoxy-5-acetylbenzoate 61414-18-4 |
2-乙酰氧基-5-乙?；郊姿峒柞?/td>
| 61414-18-4 |
詳細(xì)
|
| 2-Methylpentane-1,5-diol 42856-62-2 |
2-甲基-1,5-戊二醇 |
42856-62-2 |
詳細(xì)
|
| Fudosteine Sulfoxide |
福多司坦砜亞砜雜質(zhì) |
209665-22-5 |
詳細(xì)
|
| SodiumPicosulfateEPImpurityA |
匹可硫酸鈉EP雜質(zhì)A |
51264-33-6 |
詳細(xì)
|
| SodiumPicosulfateEPImpurityASodiumSalt |
匹可硫酸鈉EP雜質(zhì)A鈉鹽 |
32500-19-9 |
詳細(xì)
|
| Baricitinib Impurity |
1627504-41-9 |
1627504-41-9 |
詳細(xì)
|
| Ruxolitinib Hydroxy Impurity |
巴里替尼雜質(zhì)5 |
1187595-89-6 |
詳細(xì)
|
| Baricitinib Impurity |
巴瑞克替尼雜質(zhì)04 |
2497340-56-2 |
詳細(xì)
|
| Baricitinib Acetic Acid Impurity |
巴瑞替尼雜質(zhì) 17 |
2271228-52-3 |
詳細(xì)
|
| Ruxolitinib Diamine |
魯索利尼雜質(zhì)G |
952518-97-7 |
詳細(xì)
|
| Baricitinib Acetamide Impurity |
巴瑞克替尼雜質(zhì)01 |
2271228-51-2 |
詳細(xì)
|
| (R)-N-Desacryloyl N-3-Propionyl Ibrutinib |
(R)-1-[3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]-3-chloropropan-1-one |
1288338-96-4 |
詳細(xì)
|
| Ibrutinib Impurity/(S)-3-(4-phenoxyphenyl)-1-(piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine |
(S)-3-(4-phenoxyphenyl)-1-(piperidin-3-yl) |
1642630-12-3 |
詳細(xì)
|
| (R)-1-(3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)ethan-1-one |
依魯替尼雜質(zhì)31 |
1288338-95-3 |
詳細(xì)
|
| (6S)-5,6-Dihydro-6-methyl-4H-thieno[2,3-b]thiopyran-4-one7,7-dioxide |
多佐胺雜質(zhì) |
148719-91-9 |
詳細(xì)
|
| Ethyl 5-amino-1-(2-fluorobenzyl)-1H-pyrazole-3-carboxylate |
5-氨5-氨基-1-(2-氟芐基)-1H-吡唑-3-羧酸乙酯基-1-(2-氟芐基)-1H-吡唑-3-羧酸乙酯 |
256504-39-9 |
詳細(xì)
|
| LidocaineEPImpurityKHCl |
利多卡因EP雜質(zhì)K鹽酸鹽 |
50295-20-0 |
詳細(xì)
|
| TicagrelorImpurity29 |
替格瑞洛雜質(zhì) |
1823431-32-8 |
詳細(xì)
|
| TicagrelorImpurity46 |
替格瑞洛雜質(zhì) |
1482484-62-7 |
詳細(xì)
|
| (R)-Medetomidine HCl |
鹽酸左美托嘧啶 |
190000-46-5 |
詳細(xì)
|
| 2,2,8,8-Tetramethylnonanedioic acid |
2,2,8,8-四甲基壬二酸 |
30313-67-8 |
詳細(xì)
|
| 1,2,4-Trimethoxy-5-(2,4,5-trimethoxyphenyl)benzene |
間苯三酚雜質(zhì)D |
1702-67-6 |
詳細(xì)
|
| Beclomethasone Dipropionate EP Impurity F |
二丙酸倍氯米松EP雜質(zhì)F |
887130-69-0 |
詳細(xì)
|
| Beclomethasone Dipropionate EP Impurity A |
二丙酸倍氯米松EP雜質(zhì)A |
69224-79-9 |
詳細(xì)
|
| Beclomethasone Dipropionate EP Impurity L |
二丙酸倍氯米松EP雜質(zhì)L |
114371-33-4 |
詳細(xì)
|
| Beclomethasone Dipropionate EP Impurity N |
二丙酸倍氯米松EP雜質(zhì)N |
1204582-47-7 |
詳細(xì)
|
| 1-(4-Methanesulfinylphenyl)ethan-1-one |
1-(4-甲亞磺?；交?乙-1-酮 |
32361-73-2 |
詳細(xì)
|
| Octadecanedioic Acid |
十八烷二酸 |
871-70-5 |
詳細(xì)
|
| Octadecanedioic acid mono-tert‐butyl ester |
十八烷二酸單叔丁酯 |
843666-40-0 |
詳細(xì)
|
| Desmethyl Etoricoxib |
依托考昔去甲基雜質(zhì) |
202409-31-2 |
詳細(xì)
|
| FormoterolEPImpurityA(MixtureofDiastereomers) |
福莫特羅雜質(zhì)13 |
150513-24-9 |
詳細(xì)
|
| IsotretinoinEPImpurityH |
4-酮13-順式維甲酸 |
71748-58-8 |
詳細(xì)
|
| CyclophosphamideImpurityB |
環(huán)磷酰胺雜質(zhì)B |
22089-17-4 |
詳細(xì)
|
| CyclophosphamideMonochloroImpurity |
環(huán)磷酰胺相關(guān)化合物B |
158401-52-6 |
詳細(xì)
|
| NitazoxanideImpurity3 |
硝唑尼特雜質(zhì)3 |
952686-58-7 |
詳細(xì)
|
| Fluconazole EPImpurity C |
氟康唑EP雜質(zhì)C |
514222-44-7 |
詳細(xì)
|
| Adapalene EP Impurity C |
阿達(dá)帕林EP雜質(zhì)C |
43109-77-9 |
詳細(xì)
|
| Scopolamine EP Impurity B |
東莨菪堿 EP 雜質(zhì) B |
535-26-2 |
詳細(xì)
|
| LoxoprofenRing-openingImpurity |
洛索洛芬開環(huán)雜質(zhì) |
1091621-61-2 |
詳細(xì)
|
| LevothyroxineAcetamideImpurity |
左甲狀腺素乙酰胺雜質(zhì) |
176258-88-1 |
詳細(xì)
|
| Amoxicillin EP Impurity G |
阿莫西林EP雜質(zhì)G |
188112-75-6 |
詳細(xì)
|
| Anastrozole Impurity |
阿那曲唑雜質(zhì) |
1186102-55-5 |
詳細(xì)
|
| Imatinib EP Impurity D Chloride |
伊馬替尼EP雜質(zhì)D |
1821122-73-9 |
詳細(xì)
|
| Dutasteride EP Impurity E |
度他雄胺EP雜質(zhì)E |
2102935-76-0 |
詳細(xì)
|
| Azacitidine USP RC C |
阿扎胞苷雜質(zhì) |
2508-80-7 |
詳細(xì)
|
| Artemether Impurity/(2S,3R,6RS)-2-(3-Oxobutyl)-3-methyl-6-[(R)-2-propanal]cyclohexanone |
蒿甲醚雜質(zhì) |
1093625-96-7 |
詳細(xì)
|
| Axitinib Sulfoxide |
阿昔替尼雜質(zhì) |
1347304-18-0 |
詳細(xì)
|
| Amlodipine EP Impurity H |
氨氯地平雜質(zhì)H |
318465-73-5 |
詳細(xì)
|
| CetirizineEPImpurityEDiHCl |
西替利嗪雜質(zhì)E |
83881-56-5 |
詳細(xì)
|
| 1’-HydroxyBilastine |
比拉斯汀雜質(zhì)5 |
1638785-23-5 |
詳細(xì)
|
| BenzydamineEPImpurityBHCl |
1-Propanamine, 3-[[1,5-bis(phenylmethyl)-1H-indazol-3-yl]oxy]-N,N-dimethyl-, hydrochloride (1:1) |
2196183-71-6 |
詳細(xì)
|
| NaratriptanN-oxide |
納拉曲坦N氧化物 |
1159977-52-2 |
詳細(xì)
|
| 2-Propenylpropylpropanedioic Acid Diethyl Ester |
2-Propenylpropylpropanedioic Acid Diethyl Ester |
59726-38-4 |
詳細(xì)
|
| Benserazide Trihydroxybenzylhydrazine Impurity |
三羥芐肼 |
3614-72-0 |
詳細(xì)
|
| Rosuvastatin EP Impurity G Sodium Salt |
瑞舒伐他汀EP雜質(zhì)G鈉鹽 |
1242184-42-4 |
詳細(xì)
|
| OndansetronEPImpurityB |
昂丹司瓊EP雜質(zhì)B |
1076198-52-1 |
詳細(xì)
|
| PuberulicAcid |
軟毛青霉酸 |
99-23-0 |
詳細(xì)
|
| Adapalene EP Impurity B |
阿達(dá)帕林EP雜質(zhì)B |
1346599-76-5 |
詳細(xì)
|
| Azilsartan Impurity |
阿齊沙坦雜質(zhì) |
1403474-78-1 |
詳細(xì)
|
| Azilsartan Impurity |
阿齊沙坦雜質(zhì) |
139481-33-7 |
詳細(xì)
|
| Azilsartan Impurity |
阿齊沙坦雜質(zhì) |
1442400-65-8 |
詳細(xì)
|
| LevofloxacinEPImpurityGHCl |
左氧氟沙星相關(guān)物質(zhì)E |
1346603-62-0 |
詳細(xì)
|
| Denitronitazoxanide |
硝唑尼特雜質(zhì) |
402848-76-4 |
詳細(xì)
|
| Isosilybin B |
異水飛薊賓B |
142796-22-3 |
詳細(xì)
|
| GemfibrozilEPImpurityD |
吉非貝齊EP雜質(zhì)D |
1798429-95-4 |
詳細(xì)
|
| 4,4'-Dichloro-3,3'-bis(4-ethoxybenzyl)-1,1'-biphenyl/1-Chloro-4-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-2-[(4-ethoxyphenyl)methyl]benzene |
達(dá)格列凈雜質(zhì) |
2176485-21-3 |
詳細(xì)
|
| N-NitrosoVonoprazan |
沃諾拉贊雜質(zhì)171 |
2932441-73-9 |
詳細(xì)
|
| Gly-Pro-Ser-Gly-Glu-Arg-Gly-Pro-Hyp/L-Proline, glycyl-L-prolyl-L-serylglycyl-L-α-glutamyl-L-arginylglycyl-L-prolyl-4-hydroxy-, (4R)- (ACI) |
606291 |
1029806-76-5 |
詳細(xì)
|
| Asn-Gly-Leu-Pro-Gly-Pro-Ile-Gly-Hyp/L-Proline, L-asparaginylglycyl-L-leucyl-L-prolylglycyl-L-prolyl-L-isoleucylglycyl-4-hydroxy-, (4R)- (9CI, ACI) |
606290 |
620583-64-4 |
詳細(xì)
|
| Azilsartan Impurity |
阿齊沙坦雜質(zhì) |
1397836-49-5 |
詳細(xì)
|
| Linagliptin Dimer Impurity |
利格列汀二聚體雜質(zhì) |
1418133-47-7 |
詳細(xì)
|
| Isosilybin A |
異水飛薊賓A |
142796-21-2 |
詳細(xì)
|
| Azilsartan Impurity |
阿齊沙坦雜質(zhì) |
139481-47-3 |
詳細(xì)
|
| 2-(1-cyclohexenyl)ethylamine |
環(huán)己烯乙胺 |
3399-73-3 |
詳細(xì)
|
| 1,3-Dibromo-5-(tert-butyl)-2-nitrobenzene |
1,3-二溴-5-(叔丁基)-2-硝基苯 |
2828612-34-4 |
詳細(xì)
|
| SuvorexantRegioisomer(5R) |
Suvorexant Impurity 2 |
1276666-19-3 |
詳細(xì)
|
| N-Fmoc-3R-hydroxypyrrolidine-5S-methanol |
(2S,4R)-(9H-fluoren-9-yl)methyl 4-hydroxy-2-(hydroxymethyl)pyrrolidine-1-carboxylate |
163671-09-8 |
詳細(xì)
|
| Dodecanedioic acid, mono(phenylmethyl) ester |
十二烷二酸單芐酯 |
88353-04-2 |
詳細(xì)
|
| FurosemideEPImpurityC |
呋塞米EP雜質(zhì)C |
3086-91-7 |
詳細(xì)
|
| NA |
甲基潑尼松龍乙丁酸酯 |
86413-29-8 |
詳細(xì)
|
| CarbamazepineEPImpurityA |
卡馬西平EP雜質(zhì)A |
3564-73-6 |
詳細(xì)
|
| Azilsartan Impurity |
阿齊沙坦雜質(zhì) |
632322-61-3 |
詳細(xì)
|
| Azilsartan Impurity |
阿齊沙坦雜質(zhì) |
1586011-04-2 |
詳細(xì)
|
| PantoprazoleMagnesiumDihydrate |
|
259669-63-1 |
詳細(xì)
|
| 11β-Hydroxyboldione |
甲基潑尼松龍雜質(zhì) |
898-84-0 |
詳細(xì)
|
| Azilsartan Impurity |
阿齊沙坦雜質(zhì) |
1696392-11-6 |
詳細(xì)
|
| AmbroxolMonobromineImpurity |
氨溴索雜質(zhì) |
101900-43-0 |
詳細(xì)
|
| Azilsartan Impurity |
阿齊沙坦雜質(zhì) |
1821386-21-3 |
詳細(xì)
|
| Lys-Hyp-Gly-Glu-Pro-Gly-Pro-Lys-Gly/Glycine, N-[N2-[1-[N-[1-[N-[N-(trans-4-hydroxy-1-L-lysyl-L-prolyl)glycyl]-L-α-glutamyl]-L-prolyl]glycyl]-L-prolyl]-L-lysyl] |
Lys-Hyp-Gly-Glu-Pro-Gly-Pro-Lys-Gly/Glycine,?N-[N2-[1-[N-[1-[N-[N-(trans-4-hydroxy-1-L-lysyl-L-prolyl)glycyl]-L-偽-glutamyl]-L-prolyl]glycyl]-L-prolyl]-L-lysyl] |
81100-00-7 |
詳細(xì)
|
| Azilsartan Impurity |
阿齊沙坦雜質(zhì) |
147404-76-0 |
詳細(xì)
|
| Norethynodrel |
異炔諾酮 |
68-23-5 |
詳細(xì)
|
| Azilsartan Impurity |
阿齊沙坦雜質(zhì) |
1993494-84-0 |
詳細(xì)
|
| SertralineEPImpurityDHCl |
舍曲林EP雜質(zhì)D鹽酸鹽 |
2378750-29-7 |
詳細(xì)
|
| IsothipendylImpurity1HCl |
異噻吩基雜質(zhì)1 HCl |
132962-42-6 |
詳細(xì)
|
| 1,1-diprop-2-enoxybutane |
米洛巴林中間體 |
35020-94-1 |
詳細(xì)
|
| Cetirizine EP Impurity C DiHCl Salt |
鹽酸西替利嗪EP雜質(zhì)C二鹽酸鹽 |
2702511-37-1 |
詳細(xì)
|
| PhloroglucinolImpurity2 |
三甲基間苯三酚雜質(zhì) |
96259-88-0 |
詳細(xì)
|
| Hydrochlorothiazide5-ChloroImpurity |
氫氯噻嗪雜質(zhì) |
856302-12-0 |
詳細(xì)
|
| Baricitinib Impurity |
巴瑞替尼雜質(zhì)9 |
1187594-34-8 |
詳細(xì)
|
| rac-Mirabegron |
米拉貝隆雜質(zhì) |
1330277-46-7 |
詳細(xì)
|
| BenzylideneCamphorSulfonicAcid/4-[(4,7,7-Trimethyl-3-oxobicyclo[2.2.1]hept-2-ylidene)methyl]benzenesulfonicacid 56039-58-8 |
亞芐基樟腦磺酸 |
56039-58-8 |
詳細(xì)
|
| MacitentanImpurity9/2-[[5-(4-Bromophenyl)-6-[[(propylamino)sulfonyl]amino]-4-pyrimidinyl]oxy]-aceticacid 1433875-14-9 |
ACT 373898 |
1433875-14-9 |
詳細(xì)
|
| (2R,3R,4R,5S)-2,3,4,5,6-pentahydroxyhexyl4-hydroxybenzoate 334948-52-6 |
(2R,3R,4R,5S)-2,3,4,5,6-五羥基己基4-羥基苯甲酸酯 |
334948-52-6 |
詳細(xì)
|
| 9β,11β-epoxy-16β-methylandrosta-1,4-diene-3,17-dione |
|
1192715-48-2 |
詳細(xì)
|
| 3,3'-((2-(12-(benzyloxy)-12-oxododecanamido)-2-((2-carboxyethoxy)methyl)propane-1,3-diyl)bis(oxy))dipropionic acid |
3,3'-((2-(12-(芐氧基)-12-氧代十二烷酰胺基)-2-((2-羧乙氧基)甲基)丙烷-1,3-二基)雙(氧基))二丙酸 |
2241043-42-3 |
詳細(xì)
|